CRIS (STOCKS)
Curis Inc
$0.441700
+0.020600 (+4.89%)
Prev close: $0.421100
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- James E. Dentzer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $17.26M
- Employees
- 33
- P/E (TTM)
- -0.35
- P/B (TTM)
- 1.32
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-1.25 | $-0.41 | -0.8420 | -206.37% |
|
Dec 2025 (Q4)
|
$-0.50 | $-0.46 | -0.0410 | -8.93% |
|
Sep 2025 (Q3)
|
$-0.49 | $-0.59 | +0.0996 | +16.89% |
|
Jun 2025 (Q2)
|
$-0.68 | $-0.91 | +0.2278 | +25.09% |
Financial Statements
| Revenues | $7.06M |
| Costs And Expenses | $41.33M |
| Nonoperating Income/Loss | -$14.09M |
| Depreciation and Amortization | $118.00K |
| Operating Income/Loss | -$7.08M |
| Income/Loss From Continuing Operations After Tax | -$21.17M |
| Income/Loss From Continuing Operations Before Tax | -$34.61M |
| Net Income/Loss | -$21.17M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$21.17M |
| Net Income/Loss Available To Common Stockholders, Basic | -$21.17M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.81 |
| Diluted Earnings Per Share | -$0.81 |
| Basic Average Shares | 48,541,770 |
| Diluted Average Shares | 48,541,770 |
| Assets | $29.69M |
| Current Assets | $16.61M |
| Cash | $15.00M |
| Other Current Assets | $1.61M |
| Noncurrent Assets | $13.08M |
| Fixed Assets | $54.00K |
| Other Non-current Assets | $13.02M |
| Liabilities | $16.98M |
| Current Liabilities | $14.97M |
| Accounts Payable | $6.74M |
| Wages | $1.35M |
| Other Current Liabilities | $6.88M |
| Noncurrent Liabilities | $2.01M |
| Equity | $12.71M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $12.71M |
| Liabilities And Equity | $29.69M |
| Net Cash Flow From Operating Activities | -$28.95M |
| Net Cash Flow From Operating Activities, Continuing | -$28.95M |
| Net Cash Flow From Investing Activities | -$7.16M |
| Net Cash Flow From Investing Activities, Continuing | -$7.16M |
| Net Cash Flow From Financing Activities | $21.17M |
| Net Cash Flow From Financing Activities, Continuing | $21.17M |
| Net Cash Flow | -$14.94M |
| Net Cash Flow, Continuing | -$14.94M |
| Comprehensive Income/Loss | -$21.17M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$21.17M |
| Other Comprehensive Income/Loss | -$12.57M |